Skip to search formSkip to main contentSkip to account menu

vaccine development

Known as: development vaccine, development vaccines, developments vaccines 
Suspensions of killed or attenuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for… 
National Institutes of Health

Related topics

Related topics

1 relation
Vaccine Testing

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Advances in HIV-1 Vaccine Development
An efficacious HIV-1 vaccine is regarded as the best way to halt the ongoing HIV-1 epidemic. However, despite significant efforts… 
Highly Cited
2010
Highly Cited
2010
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.
Highly Cited
2007
Highly Cited
2007
A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors.
Review
2006
Review
2006
HIV vaccines: new frontiers in vaccine development.
A human immunodeficiency virus (HIV) vaccine is the most promising and feasible strategy to prevent the events during acute… 
Review
2001
Review
2001
Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain?
Highly Cited
1996
Highly Cited
1996
A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule.
Review
1996
Review
1996
Papillomavirus-like particles for serology and vaccine development.
Genital infection with high-risk human papillomaviruses (HPV) has been etiologically linked with the development of cervical and… 
Review
1996
Review
1996
Strategies involved in developing an effective vaccine for EBV-associated diseases.
Highly Cited
1987
Highly Cited
1987
The ISCOM: an immunostimulating complex.
Highly Cited
1976
Highly Cited
1976
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development
Dengue virus, type 2, in viremic human sera and after passage in cell cultures produces mixtures of small and large plaques when… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)